Patent details

Basic Information

Publication number:

EP2087001

PCT Application Number:

PCT/US/2007/023217

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP078616844

PCT Publication Number:

WO/2008/057461

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF

French Title of Invention:

RÉCEPTEUR ALK1 ET ANTAGONISTES DE LIGANDS ET UTILISATIONS DE CEUX-CI

German Title of Invention:

ALK1-REZEPTOR- UND LIGAND-ANTAGONISTEN UND IHRE VERWENDUNG

SPC Number:

Dates

Filing date:

02/11/2007

Grant date:

26/10/2016

EP Publication Date:

26/10/2016

PCT Publication Date:

15/05/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/08/2009

EP B1 Publication Date:

26/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/11/2016

Expiration date:

02/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/11/2007

 

 

Name:

Acceleron Pharma Inc.

Address:

128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

KUMAR Ravindra

Address:

United States (US)

2

Name:

KNOPF John

Address:

United States (US)

3

Name:

PEARSALL Robert Scott

Address:

United States (US)

4

Name:

GRINBERG Asya

Address:

United States (US)

5

Name:

SEEHRA Jasbir

Address:

United States (US)

Priority

Priority Number:

856592 P

Priority Date:

02/11/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/71;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages